Technology & Devices

FDA Clears First-of-Kind Device to Treat Patients with Dialysis-Related Amyloidosis

US health regulators cleared use of a first-of-its-kind device to treat dialysis-related amyloidosis (DRA). The US Food and Drug Administration (FDA) authorized use of Lixelle Beta 2-microglobulin Apheresis Column under its pathway for medical devices that treat rare conditions. The device is used to treat DRA, a chronic, progressive condition …

Read More »

Mayo and Gentag Partner to Develop Wearable Biosensors for Treating Diabetes

Mayo Clinic and Gentag, Inc. have teamed up to develop next-generation, wearable biosensors designed to fight diabetes and obesity. The companies have reached a joint intellectual property (IP) agreement to develop the first-of-its-kind, wearable patch sensors, which are wireless and the size of a small bandage. The sensors are designed …

Read More »

Boston Scientific Buys Endo’s Urology Device Business for $1.6 Billion

Medical device maker Boston Scientific Corp is buying Endo International’s men’s health and prostate businesses for up to $1.65 billion. The companies have entered into a definitive agreement, under which Boston Scientific will acquire the American Medical Systems urology profile, which includes the Men’s Health and Prostate Health businesses, for …

Read More »

Intermountain Cancer Genomics Uses DNAnexus Technology to Bring Precision Medicine to Patients

DNAnexus Inc., a pioneer in cloud-based genome informatics and data management, recently announced that Intermountain Cancer Genomics is now utilizing its technology platform for the center’s personalized treatment options for cancer patients. The DNAnexus platform allows Intermountain Cancer Genomics to run its bioinformatics pipeline in the cloud, providing unmatched computational …

Read More »

Genmab Enters DuoBody Technology Agreement with BioNovion in Immuno-Oncology

Genmab A/S and BioNovion struck a deal to evaluate several DuoBody product candidates targeting immune checkpoints. The companies announced that they have entered into a co-development and commercialization agreement to evaluate the product candidates. Genmab and BioNovion will contribute panels of antibodies for the creation of bispecific antibody products using …

Read More »

PARI’s Electronic Nebulizer Receives FDA Approval for Cystic Fibrosis Patients

The US Food and Drug Administration (FDA) has approved the first electronic nebulizer to deliver cystic fibrosis patients their therapy. The agency approved PARI’s eRapid nebulizer system to deliver Genentech’s Pulmozyme (dornase alfa [recombinant human DNase] for treatment of cystic fibrosis (CF). According to PARI, eRapid cuts the average treatment …

Read More »

mHealth Tools Significantly Improve Adherence Among HIV Patients

New mobile health (mHealth) tools have demonstrated effectiveness in aiding HIV patients better manage their disease through improved medication adherence. After analyzing data regarding the effectiveness in mobile pharmacy apps in helping HIV patients, mscripts and Avella Specialty Pharmacy found that HIV patients using a mobile app which provides refill …

Read More »